This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX World Congress
29th-30th April 2024
Business Design CentreLondon

Olivia Cavlan
Chief Corporate Development & Strategy Officer at Alchemab Therapeutics

Agenda Sessions

  • Synergizing Innovation: Uniting Biotech and Pharma for Advancing AI in Healthcare